Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma CellsLaurie Ma, Jim Dimitroulakos|PLoS ONE|2012Cited by 48
Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR InhibitorsTong Zhao, Jim Dimitroulakos|PLoS ONE|2010Cited by 32
Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast CancerMohamed S. Hasim, Jim Dimitroulakos|Translational Oncology|2018Cited by 31
Lovastatin‐induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinalNima Niknejad, Jim Dimitroulakos|International Journal of Cancer|2013Cited by 25
Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combinationCarly St. Germain, Jim Dimitroulakos|Cancer Cell International|2010Cited by 24